دورية أكاديمية
Encorafenib with Binimetinib for the Treatment of Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
| العنوان: | Encorafenib with Binimetinib for the Treatment of Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal |
|---|---|
| المؤلفون: | Houten, RachelAff1, Greenhalgh, Janette, Mahon, James, Nevitt, Sarah, Beale, Sophie, Boland, Angela, Lambe, Tosin, Dundar, Yenal, Kotas, Eleanor, McEntee, Joanne |
| المصدر: | PharmacoEconomics - Open: Healthcare Interventions and Outcomes. 5(1):13-22 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 25094262 25094254 |
|---|---|
| DOI: | 10.1007/s41669-020-00206-x |